Login
$BMY
$61.61 +$0.13 (0.21%) Close

Company Executives

$BMY Management Team

Mr. Adam Lenkowsky

Executive Vice President

Chief Commercialization Officer

Member of the Leadership Team

Age 52
Compensation -
Sex Male

Dr. Christopher Boerner

Chairman of the Board

Chief Executive Officer

Age 54
Compensation $18.79M USD
Sex Male

Mr. David Elkins

Executive Vice President

Chief Financial Officer

Member of the Leadership Team

Age 57
Compensation $8.708M USD
Sex Male

Mr. Benjamin Hickey

President - RayzeBio Organization

Member of the Leadership Team

Age 50
Compensation -
Sex Male

Ms. Lynelle Hoch

President

Cell Therapy Organization

Member of the Leadership Team

Age 52
Compensation -
Sex Female

Ms. Amanda Poole

Executive Vice President

Chief People Officer

Member of the Leadership Team

Age 50
Compensation -
Sex Female

Mr. Greg Meyers

Executive Vice President

Chief Digital and Technology Officer

Member of the Leadership Team

Age 52
Compensation -
Sex Male

Ms. Cari Gallman

Executive Vice President

General Counsel and Chief Policy Officer

Age 45
Compensation -
Sex Female

Mr. Robert Plenge

Executive Vice President

Chief Research Officer

Head of Research

Member of the Leadership Team

Age 54
Compensation -
Sex Male

Ms. Karin Shanahan

Executive Vice President

Global Product Development & Supply

Member of the Leadership Team

Age 60
Compensation $6.567M USD
Sex Female

Mr. Phil Holzer

Senior Vice President

Controller

Age 49
Compensation -
Sex Male
Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
6.1 years
from year joined
CEO also chairs the board
Yes
Christopher S. Boerner, Ph.D.
Director Age On board Independent Committees Other public boards Pay Source
Christopher S. Boerner, Ph.D.
55 2023
3 years
Not independent None stated Colgate-Palmolive Company Paid as CEO
Theodore R. Samuels
71 2017
9 years
Independent
Committee on Directors and Corporate Governance · Chair Audit Committee
Centene Corporation, Iron Mountain Incorporated Not stated
Peter J. Arduini
61 2016
10 years
Independent
Compensation and Management Development Committee · Chair
GE Healthcare Not stated
Deepak L. Bhatt, M.D., M.P.H., M.B.A.
58 2022
4 years
Independent
Science & Technology Committee Compensation and Management Development Committee
None stated Not stated
Julia A. Haller, M.D.
71 2019
7 years
Independent
Science & Technology Committee · Chair Committee on Directors and Corporate Governance
None stated Not stated
Manuel Hidalgo Medina, M.D., Ph.D.
58 2021
5 years
Independent
Committee on Directors and Corporate Governance Science & Technology Committee
Guardant Health, Inc. Not stated
Michael R. McMullen
65 2024
2 years
Independent
Audit Committee Compensation and Management Development Committee
KLA Corporation Not stated
Paula A. Price
64 2020
6 years
Independent
Audit Committee Committee on Directors and Corporate Governance
Accenture plc, Warner Brothers Discovery, Mondelez International, Inc. Not stated
Derica W. Rice
61 2020
6 years
Independent
Audit Committee · Chair Compensation and Management Development Committee
Target Corporation, The Walt Disney Company, The Carlyle Group Not stated
Karen H. Vousden, Ph.D.
68 2018
8 years
Independent
Compensation and Management Development Committee Science & Technology Committee
None stated Not stated
Phyllis R. Yale
68 2019
7 years
Independent
Audit Committee Science & Technology Committee
Davita, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

We could not read related-party transactions reliably

Rather than show a list that might be incomplete, we show nothing. They are in the proxy filed Mar 25, 2026, in its related person transactions section.

Read them in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support